 |
 |

Respiratory Paralysis During Treatment of Hypertension With Trimethaphan Camsylate
Robert C. Dale, MD;
Edward T. Schroeder, MD
Arch Intern Med. 1976;136(7):816-818.
Abstract
Four cases are reported in which respiratory arrest occurred coincident with the intravenous administration of large doses of trimethaphan camsylate (Arfonad) to control hypertension. The mechanism of the respiratory depression is unknown, but it may have been related to a direct effect of trimethaphan on the respiratory center or to a curare-like effect of the drug. Close monitoring of ventilatory capacity should be maintained in all patients treated with trimethaphan.
(Arch Intern Med 136:816-818, 1976)
Author Affiliations
From the Department of Medicine, Upstate Medical Center, State University of New York, Syracuse, NY.
Footnotes
Received for publication Aug 29, 1975; accepted Dec 23.
Reprint requests to Department of Medicine, State University Hospital, Syracuse, NY 13210 (Dr Schroeder).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Uncoupling of the Baroreflex by NN-Cholinergic Blockade in Dissecting the Components of Cardiovascular Regulation
Shannon et al.
Hypertension 1998;32:101-107.
ABSTRACT
| FULL TEXT
NN-Nicotinic Blockade as an Acute Human Model of Autonomic Failure
Jordan et al.
Hypertension 1998;31:1178-1184.
ABSTRACT
| FULL TEXT
Hypertensive Encephalopathy: Recognition and Management
Ram
Arch Intern Med 1978;138:1851-1853.
ABSTRACT
|